Utah Medical Products logo
Utah Medical Products UTMD
$ 58.18 0.14%

Quarterly report 2025-Q3
added 11-14-2025

report update icon

Utah Medical Products Financial Ratios 2011-2025 | UTMD

Annual Financial Ratios Utah Medical Products

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

57.7 74.2 79.5 89.6 25.5 18.8 40.2 19.1 18.0 18.8 17.7 14.9 14.7

P/S

20.1 24.9 25.4 25.5 8.0 8.3 8.3 5.9 5.3 5.2 5.0 3.6 2.9

EPS

4.6 4.5 4.0 3.0 4.0 5.0 2.3 3.2 3.2 3.0 3.1 2.8 2.0

EV (Enterprise Value)

162 M 272 M 276 M 263 M 342 M 308 M 316 M 213 M 199 M 211 M 207 M 168 M 138 M

EBITDA per Share

4.79 5.61 5.35 3.93 6.56 5.82 5.86 5.05 4.98 5.18 4.78 4.97 4.02

EV/EBITDA

14.1 12.7 13.6 13.7 13.9 10.8 10.1 10.2 10.9 8.4 8.5

PEG

-278.23 28.68 16.49 -41.82 -1.21 0.16 -1.39 7.51 4.33 -81.17 1.72 0.43 0.65

P/B

1.9 3.0 3.1 3.0 3.7 3.9 4.4 3.4 3.1 3.3 3.3 3.0 2.7

P/CF

11.1 16.0 15.5 15.2 -83.8 21.2 22.3 20.7 15.7 15.0 16.8 11.4 9.8

ROE %

3.34 3.99 3.86 3.32 14.57 20.85 10.89 17.51 17.00 17.63 18.83 19.95 18.19

ROA %

3.16 3.68 3.57 3.05 13.41 18.60 9.17 15.84 14.96 14.03 14.13 13.22 9.71

ROCE %

13.08 17.32 17.62 13.33 16.58 19.78 21.74 22.00 20.84 22.47 20.28 21.99 17.74

Current Ratio

19.0 12.9 13.6 12.5 15.9 11.6 9.3 11.5 8.1 3.3 3.2 2.4 1.8

DSO

132.1 143.4 130.5 134.4 36.9 34.4 31.9 29.8 41.5 41.6 39.1 38.1 45.6

DIO

166.3 140.0 129.0 144.1 144.7 125.9 127.4 106.2 95.9 109.1 105.8 97.8 118.2

DPO

18.0 18.0 15.6 20.7 23.0 22.7 22.7 21.2 14.8 20.8 17.4 22.5 21.8

Operating Cycle

298.4 283.5 259.5 278.6 181.6 160.3 159.4 136.0 137.4 150.7 144.9 135.9 163.8

Cash Conversion Cycle

280.5 265.5 243.9 257.9 158.6 137.6 136.7 114.9 122.5 129.9 127.5 113.5 142.0

All numbers in USD currency

Quarterly Financial Ratios Utah Medical Products

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.82 0.94 0.92 - 1.02 0.98 1.09 - 1.08 1.16 1.16 - 1.18 1.13 0.97 - 1.15 0.94 0.83 - 0.81 0.36 0.85 - 1 0.95 0.84 - 1.81 1.15 1.1 - 0.97 1.04 0.95 - 0.78 0.87 0.86 - 0.81 0.78 0.71 - 0.75 0.76 0.73 - 0.69 0.71 0.74 - 0.74 0.65 0.76 - 0.62 0.55 0.37

EBITDA per Share

- - 1.01 - - - 1.12 - - - 1.27 - 1.54 1.47 1.28 - 1.53 1.4 1.11 - 1.12 0.63 1.09 - 1.32 1.3 1.15 - 1.33 1.46 1.39 - 1.39 1.44 1.32 - 1.17 1.23 1.19 - 1.19 1.14 1.07 - 1.2 1.17 1.07 - 1.1 1.08 1.09 - 1.21 1.06 1.35 - 1.12 0.99 0.67

ROE %

10.29 10.93 11.12 8.75 11.93 12.24 12.91 10.20 14.16 14.93 15.30 11.01 14.87 14.74 14.11 13.75 13.22 12.25 10.33 10.50 11.50 12.31 14.52 14.57 14.07 18.00 19.36 20.85 13.81 10.85 10.96 10.89 18.36 17.96 17.71 13.59 17.97 18.10 17.59 12.39 16.77 16.76 16.96 12.98 17.22 17.09 17.05 13.10 18.44 19.54 19.90 15.52 21.01 21.16 21.31 13.63 5.49 4.86 3.28

ROA %

9.91 10.50 10.63 5.40 8.40 8.65 9.22 9.52 13.13 13.75 14.06 10.10 13.67 13.57 12.97 12.66 12.14 11.26 9.50 9.66 10.58 11.33 13.37 13.42 12.85 16.25 17.36 18.60 12.48 9.61 9.46 9.17 15.72 15.65 15.73 12.29 16.14 16.15 15.58 10.90 14.38 14.02 13.83 10.33 13.52 13.22 12.99 9.84 13.37 13.72 13.58 10.28 13.21 12.60 12.08 7.27 2.93 2.59 1.75

ROCE %

10.31 10.80 10.85 8.50 11.71 12.23 13.09 10.60 15.36 16.90 17.97 13.60 18.24 18.12 17.85 12.78 16.27 15.12 12.61 9.17 13.49 14.33 16.84 12.81 17.76 18.38 19.63 16.21 22.20 23.25 24.01 18.48 24.17 23.87 23.66 18.15 23.89 23.95 23.41 17.01 23.20 23.66 24.26 18.44 24.49 24.34 24.18 18.60 26.37 28.09 28.93 22.81 31.49 32.41 33.37 21.91 8.68 7.93 5.29

Current Ratio

32.8 37.0 22.4 24.0 23.6 21.7 - 19.0 17.4 15.0 13.1 12.9 11.6 13.4 11.3 13.6 12.2 12.4 12.0 12.5 12.5 12.5 12.5 12.6 12.6 12.6 12.6 9.3 9.3 9.3 9.3 6.3 6.3 6.3 6.3 11.0 10.4 10.4 10.4 8.3 8.3 8.3 8.3 4.9 4.9 4.9 4.9 4.0 4.0 4.0 4.0 3.0 3.0 3.0 3.0 2.1 2.1 2.1 2.1

DSO

34.2 34.7 37.8 - 33.7 - - - 25.9 26.3 34.1 - 38.6 36.2 40.2 35.3 34.3 31.7 34.4 31.2 35.7 42.6 37.0 36.6 34.6 36.5 37.0 37.0 34.7 32.9 31.8 32.4 32.6 30.5 30.4 - 30.4 27.9 34.4 - 41.9 40.0 41.3 - 40.0 40.9 42.0 - 39.4 39.5 38.2 - 37.8 39.5 37.0 - 40.1 41.6 -

DIO

177.3 176.7 190.9 - 197.2 - - - 175.8 178.5 182.9 - 149.7 127.1 133.0 - 125.9 114.5 138.5 - 142.6 148.0 147.4 - 123.3 145.2 159.3 - 120.6 124.0 122.6 - 131.9 - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

16.3 17.3 17.6 - 19.9 - - - 16.4 21.0 21.9 - 20.2 19.6 21.1 - 22.4 19.2 18.5 - 18.1 18.7 21.2 - 19.6 23.1 23.9 - 21.7 22.4 22.0 - 23.5 - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

211.5 211.5 228.7 - 230.9 - - - 201.7 204.8 217.0 - 188.3 163.3 173.2 35.3 160.2 146.2 172.9 31.2 178.3 190.6 184.4 36.6 158.0 181.7 196.3 37.0 155.3 157.0 154.4 32.4 164.5 30.5 30.4 - 30.4 27.9 34.4 - 41.9 40.0 41.3 - 40.0 40.9 42.0 - 39.4 39.5 38.2 - 37.8 39.5 37.0 - 40.1 41.6 -

Cash Conversion Cycle

195.2 194.2 211.1 - 211.0 - - - 185.3 183.8 195.1 - 168.2 143.7 152.1 35.3 137.8 127.0 154.4 31.2 160.3 171.8 163.3 36.6 138.4 158.6 172.4 37.0 133.6 134.6 132.4 32.4 141.0 30.5 30.4 - 30.4 27.9 34.4 - 41.9 40.0 41.3 - 40.0 40.9 42.0 - 39.4 39.5 38.2 - 37.8 39.5 37.0 - 40.1 41.6 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Utah Medical Products, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Medical instruments industry

Issuer Price % 24h Market Cap Country
BioLife Solutions BioLife Solutions
BLFS
$ 24.51 0.49 % $ 1.13 B usaUSA
Baxter International Baxter International
BAX
$ 19.45 1.57 % $ 9.92 B usaUSA
Becton, Dickinson and Company Becton, Dickinson and Company
BDX
$ 200.24 -0.32 % $ 57.6 B usaUSA
Harvard Bioscience Harvard Bioscience
HBIO
$ 0.72 -3.0 % $ 30.5 M usaUSA
Luminex Corporation Luminex Corporation
LMNX
- - $ 1.75 B usaUSA
ICU Medical ICU Medical
ICUI
$ 147.83 -0.41 % $ 3.61 B usaUSA
iRhythm Technologies iRhythm Technologies
IRTC
$ 170.06 0.73 % $ 5.31 B usaUSA
Akers Biosciences, Inc. Akers Biosciences, Inc.
AKER
- -9.52 % $ 20.6 M usaUSA
Repro Med Systems Repro Med Systems
KRMD
$ 5.73 -0.87 % $ 261 M usaUSA
LeMaitre Vascular LeMaitre Vascular
LMAT
$ 84.3 0.35 % $ 1.89 B usaUSA
Ekso Bionics Holdings Ekso Bionics Holdings
EKSO
$ 4.64 -0.64 % $ 93.5 M usaUSA
Masimo Corporation Masimo Corporation
MASI
$ 137.72 -0.45 % $ 7.34 B usaUSA
Antares Pharma, Inc. Antares Pharma, Inc.
ATRS
- - $ 955 M usaUSA
Cantel Medical Corp. Cantel Medical Corp.
CMD
- -1.18 % $ 3.4 B usaUSA
CRH Medical Corporation CRH Medical Corporation
CRHM
- - $ 282 M usaUSA
Merit Medical Systems Merit Medical Systems
MMSI
$ 86.66 -0.05 % $ 5.05 B usaUSA
Hill-Rom Holdings, Inc. Hill-Rom Holdings, Inc.
HRC
- -0.05 % $ 10.3 B usaUSA
Varian Medical Systems, Inc. Varian Medical Systems, Inc.
VAR
- -0.02 % $ 16.3 B usaUSA
OraSure Technologies OraSure Technologies
OSUR
$ 2.51 0.6 % $ 187 M usaUSA
Alcon Alcon
ALC
$ 79.51 0.9 % $ 40.4 B schweizSchweiz
AtriCure AtriCure
ATRC
$ 41.55 -1.96 % $ 1.95 B usaUSA
Atrion Corporation Atrion Corporation
ATRI
- - $ 810 M usaUSA
electroCore electroCore
ECOR
$ 4.82 1.47 % $ 26.6 K usaUSA
ResMed ResMed
RMD
$ 252.92 0.26 % $ 36.9 B usaUSA
AngioDynamics AngioDynamics
ANGO
$ 13.39 1.9 % $ 547 M usaUSA
The Cooper Companies The Cooper Companies
COO
$ 81.06 -1.24 % $ 16.1 B usaUSA
STAAR Surgical Company STAAR Surgical Company
STAA
$ 23.98 -0.62 % $ 1.18 B usaUSA
STERIS plc STERIS plc
STE
$ 253.49 0.68 % $ 25 B usaUSA
Glaukos Corporation Glaukos Corporation
GKOS
$ 112.17 3.02 % $ 5.43 B usaUSA
Haemonetics Corporation Haemonetics Corporation
HAE
$ 80.33 -3.78 % $ 4.04 B usaUSA
InfuSystem Holdings InfuSystem Holdings
INFU
$ 9.01 -2.49 % $ 186 M usaUSA
Isoray Isoray
ISR
- 0.03 % $ 108 M usaUSA
Intuitive Surgical Intuitive Surgical
ISRG
$ 557.08 2.72 % $ 198 B usaUSA
Microbot Medical Microbot Medical
MBOT
$ 2.28 -5.39 % $ 23.3 M israelIsrael
Milestone Scientific Milestone Scientific
MLSS
$ 0.36 -6.38 % $ 28.7 M usaUSA
Nephros Nephros
NEPH
$ 4.82 -3.98 % $ 50.1 M usaUSA
NeuroMetrix NeuroMetrix
NURO
- 5.05 % $ 9.02 M usaUSA
Envista Holdings Corporation Envista Holdings Corporation
NVST
$ 22.05 0.36 % $ 3.8 B usaUSA
Pro-Dex Pro-Dex
PDEX
$ 43.41 0.07 % $ 143 M usaUSA
Pulse Biosciences Pulse Biosciences
PLSE
$ 14.45 1.44 % $ 694 M usaUSA
Predictive Oncology Predictive Oncology
POAI
- - $ 32.4 M usaUSA
Stereotaxis Stereotaxis
STXS
$ 2.38 0.63 % $ 192 M usaUSA
DENTSPLY SIRONA DENTSPLY SIRONA
XRAY
$ 11.45 -1.04 % $ 2.33 B usaUSA
Repligen Corporation Repligen Corporation
RGEN
$ 159.03 1.04 % $ 8.86 M usaUSA
Retractable Technologies Retractable Technologies
RVP
$ 0.83 0.17 % $ 24.8 M usaUSA
Teleflex Incorporated Teleflex Incorporated
TFX
$ 126.56 -0.09 % $ 5.93 B usaUSA
West Pharmaceutical Services West Pharmaceutical Services
WST
$ 269.2 0.62 % $ 19.7 B usaUSA